Metabolic Response to Food in Lung Cancer
This goal of this study is to describe how unintentional weight loss influences fasting and post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.
Checked against the public recordLast updated Jul 4, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Pennington Biomedical Research Center
- Interventions being studied
- Other: Weight loss (%)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age greater than or equal to 18 years * Diagnosis of non-small-cell lung cancer * Reported weight stability or loss after cancer diagnosis * Body mass index less than or equal to 35 kilograms per meter squared * Ability to provide written informed consent * Willing and able to comply with all scheduled visits, treatment plans, lab tests, and other study procedure * Allow the collection and storage of biospecimens and data for future use Exclusion Criteria: * Prior diagnosis of diabetes mellitus (type 1 or type 2) * Currently pregnant or breastfeeding * Contraindication to consuming the liquid mixed meal * Any medications affecting gastric motility * Any other condition that, in the investigator's opinion, would preclude participation or successful compliance with the protocol
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Pennington Biomedical Research CenterBaton Rouge, Louisiana
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 4, 2025. Always confirm current availability with the study team.